Joseph Group Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Joseph Group Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72M	Buy	22,966 +253	+1%	+$27.4K	0.57%	45
2026 Q1	$2.36M	Buy	22,713 +487	+2%	+$51.4K	0.59%	42
2025 Q4	$2.32M	Buy	22,226 +95	+0.4%	+$9.56K	0.61%	42
2025 Q3	$2.05M	Buy	22,131 +889	+4%	+$77.8K	0.58%	42
2025 Q2	$1.7M	Buy	21,242 +1,907	+10%	+$152K	0.57%	43
2025 Q1	$1.67M	Buy	19,335 +1,938	+11%	+$165K	0.64%	41
2024 Q4	$1.44M	Buy	17,397 +2,317	+15%	+$199K	0.57%	43
2024 Q3	$1.31M	Buy	15,080 +2,079	+16%	+$178K	0.5%	44
2024 Q2	$1.07M	Buy	13,001 +1,272	+11%	+$101K	0.55%	43
2024 Q1	$940K	Sell	11,729 -16,136	-58%	-$1.25M	0.47%	43
2023 Q4	$2.12M	Buy	+27,865	New	+$1.99M	1.23%	21

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Joseph Group Capital Management's PJP Position: Q2 2026 in Review

Joseph Group Capital Management increased its Invesco Pharmaceuticals ETF (PJP) stake by 1.1% in Q2 2026, buying an estimated $27.4K and bringing the position to 22,966 shares worth $2.72M. The position accounts for 0.57% of the portfolio, ranked #45.

Joseph Group Capital Management first reported a position in PJP in Q4 2023 and has held it in 11 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Joseph Group Capital Management held 22,966 shares of Invesco Pharmaceuticals ETF worth $2.72M as of Q2 2026.
Joseph Group Capital Management bought 253 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $27.4K.
Invesco Pharmaceuticals ETF made up 0.57% of Joseph Group Capital Management's portfolio in Q2 2026, its #45 holding.
Joseph Group Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2023 and has held it in 11 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.